Evidence map›Paper›PMID 27043611›Full record

ArticleViruses2016

Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques.

Evan C Ewers, William D Pratt, Nancy A Twenhafel, Joshua Shamblin, Ginger Donnelly, Heather Esham, Carly Wlazlowski, Joshua C Johnson, Miriam Botto, Lisa E Hensley and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Atlas-based liver segmentation for nonhuman primate research.International journal of computer assisted radiology and surgery · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Evan C EwersDepartment of Medicine, Tripler Army Medical Center, Honolulu, HI 96859, USA. evan.c.ewers.mil@mail.mil.
William D PrattUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA. william.d.pratt4.ctr@mail.mil.
Nancy A TwenhafelDepartment of Medicine, Tripler Army Medical Center, Honolulu, HI 96859, USA. nancy.a.twenhafel.mil@mail.mil.
Joshua ShamblinUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA. joshua.d.shamblin1.civ@mail.mil.
Ginger DonnellyUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA. ginger.c.donnelly.ctr@mail.mil.
Heather EshamUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA. heather.l.esham.civ@mail.mil.
Carly WlazlowskiUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA. carly.b.wlazlowski.ctr@mail.mil.
Joshua C JohnsonIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA. joshua.johnson@nih.gov.
Miriam BottoUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA. miriam.a.botto.civ@mail.mil.
Lisa E HensleyIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA. lisa.hensley@nih.gov.
Arthur J GoffDepartment of Medicine, Tripler Army Medical Center, Honolulu, HI 96859, USA. arthur.j.goff.civ@mail.mil.
United States Army Medical Research Institute of Infectious Diseases · USTripler Army Medical Center · USNational Institutes of Health · US

Funding

Integrated Research Facility at Fort DetrickZIDAI009006 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI COE, LINDA · 2009 to 2018
$341.7M
6 · The paper itself

Abstract

Marburg virus causes severe and often lethal viral disease in humans, and there are currently no Food and Drug Administration (FDA) approved medical countermeasures. The sporadic occurrence of Marburg outbreaks does not allow for evaluation of countermeasures in humans, so therapeutic and vaccine candidates can only be approved through the FDA animal rule-a mechanism requiring well-characterized animal models in which efficacy would be evaluated. Here, we describe a natural history study where rhesus macaques were surgically implanted with telemetry devices and central venous catheters prior to aerosol exposure with Marburg-Angola virus, enabling continuous physiologic monitoring and blood sampling without anesthesia. After a three to four day incubation period, all animals developed fever, viremia, and lymphopenia before developing tachycardia, tachypnea, elevated liver enzymes, decreased liver function, azotemia, elevated D-dimer levels and elevated pro-inflammatory cytokines suggesting a systemic inflammatory response with organ failure. The final, terminal period began with the onset of sustained hypotension, dehydration progressed with signs of major organ hypoperfusion (hyperlactatemia, acute kidney injury, hypothermia), and ended with euthanasia or death. The most significant pathologic findings were marked infection of the respiratory lymphoid tissue with destruction of the tracheobronchial and mediastinal lymph nodes, and severe diffuse infection in the liver, and splenitis.

Indexed as

AnimalsBlood Cell CountBlood Coagulation TestsCytokinesFemaleKidney Function TestsLiver Function TestsMacaca mulattaMaleMarburgvirusMarburg Virus DiseaseViremiaCytokinesaerosolanimal modelfilovirusMarburg virusnonhuman primatetelemetry

Identifiers

PMID27043611
PMCPMC4848582
OpenAlexW2324183272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.